ANAB
AnaptysBio Inc
45.70$
-4.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 87.8% | 89.9% | 91.8% | 86.0% | 90.9% | 89.3% | 86.0% | 87.1% | 93.6% | 96.1% | 95.9% | 62.6% | |
| 5.4% | 8.0% | 13.2% | 16.8% | 38.8% | 25.4% | 23.4% | 13.2% | 31.1% | 65.4% | 75.4% | 42.2% | |
| 84.8% | 86.4% | 87.4% | 82.1% | 87.2% | 79.6% | 80.5% | 79.3% | 70.5% | 85.5% | 86.9% | 51.8% | |
| 0.7% | 1.5% | 1.7% | 2.1% | 2.5% | 8.4% | 4.2% | 6.4% | 21.4% | 9.3% | 7.8% | 10.0% | |
| 0.0% | 0.0% | 0.0% | 0.0% | -2.5% | – | – | – | – | – | – | – | |
| 3.9% | – | – | – | – | – | – | – | – | – | – | – | |
| 75.3% | 80.5% | 88.2% | 97.7% | 82.9% | 85.4% | 91.9% | 113.3% | 108.3% | 89.8% | 96.1% | 96.7% | |
| 8.0% | 8.3% | 8.0% | 9.5% | 8.9% | 9.4% | 10.4% | 10.6% | 10.8% | 10.6% | 12.6% | 11.2% | |
| 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.5% | 0.6% | 0.6% | 0.6% | 0.6% | 0.7% | |
| 1.3% | 1.0% | 1.1% | 1.1% | 0.7% | 0.8% | 1.5% | 1.0% | 0.8% | 1.1% | 2.3% | 1.4% | |
| 24.7% | 19.5% | 11.8% | 2.3% | 17.1% | 14.6% | 8.1% | -13.3% | -8.3% | 10.2% | 3.9% | 3.3% | |
| -117.4% | -135.7% | -162.1% | -164.9% | -149.5% | -156.9% | -189.2% | -249.7% | -232.8% | -212.0% | -250.4% | -202.4% | |
| 5.4% | 5.9% | 6.6% | 6.4% | 5.9% | 6.3% | 7.3% | 8.6% | 8.2% | 8.6% | 8.7% | 11.3% |
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.